Table 2. Aberrant expression of miRNAs in various human CSCs.
CSC | Expression | miRNAs | References |
---|---|---|---|
Breast cancer | Down | let-7a, let-7b, let-7c, let-7d, let-7e, let-7g, let-7i, miR-103, miR-107, miR-10a, miR-128a, miR-128b, miR-130a, miR-138, miR-141, miR-15a, miR-15b, miR-16, miR-17, miR-181b, miR-182, miR-183, miR-193b, miR-196a, miR-200a, miR-200a*, miR-200b, miR-200c, miR-20b, miR-210, miR-215, miR-22, miR-96 | Yu et al67; Shimono et al68 |
Up | miR-125b, miR-127, miR-132, miR-142-3p, miR-146b, miR-150, miR-155, miR-199a, miR-199a*, miR-199b, miR-212, miR-214, miR-221, miR-222, miR-223, miR-299-5p, miR-31, miR-409-3p, miR-432, miR-495 | Gal et al69 | |
Glioblastoma | Down | miR-103, miR-107, miR-16, miR-185, miR-425-5p, miR-451, miR-486 | Ji et al70 |
Up | N/A | ||
Hepatic cancer | Down | N/A | |
Up | miR-106b, miR-17, miR-181a, miR-181b, miR-181c, miR-20a, miR-25, miR-92, miR-93 | Liu et al71 | |
Prostate cancer | Down | miR-34a | |
Up | N/A | ||
Ovarian cancer | Down | miR-1181, miR-1202, miR-1207-5p | Nam et al73 |
Up | let-7f, miR-100, miR-107, miR-135b, miR-146a, miR-181a, miR-183, miR-193a-3p, miR-200a, miR-200b, miR-205, miR-21, miR-210, miR-26b, miR-29b, miR-33a, miR-34a, miR-340, miR-340*, miR-365, miR-424, miR-425, miR-449a, miR-455-3p, miR-494, miR-516a-5p, miR-517a, miR-517c, miR-522, miR-7, miR-886-3p, miR-96 | ||
Colon cancer | Down | miR-151-3p, miR-151-5p, miR-221, miR-31, miR-320d, miR-429, miR-548d-5p, miR-636 | Zhang et al72 |
Up | miR-105, miR-155, miR-16-2*, miR-181b, miR-1826, miR-185, miR-423-5p, miR-455-3p, miR-455-5p, miR-494, miR-744 |
Underlined miRNAs represent those miRNAs that show similar dysregulation (up or down) in more than one type of cancer stem cells.